Prenetics Global (PRENW) Common Equity (2021 - 2026)

Prenetics Global has disclosed Common Equity across 6 years of filings, most recently posting $121.0 million for Q1 2026.

• In Q1 2026, Common Equity fell 24.88% year-over-year to $121.0 million; the TTM figure through Mar 2026 stood at $121.0 million (down 24.88% YoY), while the FY2025 annual figure was $156.4 million, down 8.23% from the prior year.
• Common Equity eased to $121.0 million in Q1 2026, from $156.4 million in the prior quarter.
• Over the last five years, Common Equity for PRENW reached as high as $233.5 million in Q1 2023 and fell as low as $3.1 million in Q4 2022.
• The 5-year median for Common Equity is $175.2 million (2024), against an average of $170.5 million.
• Annual changes were most pronounced in 2023 — Common Equity surged 6521.83% — and 2026, when it decreased 24.88%.
• A 5-year view of Common Equity shows it stood at $3.1 million in 2022, then surged by 6521.83% to $206.4 million in 2023, then slipped by 17.43% to $170.4 million in 2024, then retreated by 8.23% to $156.4 million in 2025, then retreated by 22.6% to $121.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $121.0 million, $156.4 million, and $161.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.